Cannabis for Arthritis

"The most recent information available from clinicaltrials.gov suggests that this clinical trial is still recruiting patients. The study was first posted on 5/18/2022 and has not had any changes since then."

"Up to 76 patients that have been diagnosed with psoriatic arthritis may be enrolled in this study, so long as they are between 18 and 65 years old. To qualify, potential participants must meet the following conditions: a current diagnosis of RA or PA where active arthritis is not being adequately controlled by standard medication (if taking prescribed steroids, NSAIDs, and/or DMARDS), stable use for at least one month prior to enrollment (this usage must be maintained throughout the study), English or Spanish fluency, negative urine toxicology screen, negative pregnancy test result, non-nursing status, effective birth control for both genders throughout the"

"This study's age requirements state that, at a minimum, participants must be 18 years old whereas the maximum age is 65."

"There is some supporting data for the safety of Vaporized cannabis: medium THC/medium CBD, but not enough to prove efficacy. It received a score of 2."

"The information on clinicaltrials.gov supports that this trial is actively looking for participants. The posting date was 5/18/2022 and has not been updated since, meaning the search is still active. They are recruiting for a total of 76 individuals from 1 location."

"As of now, there are 35 ongoing studies investigating the effects of vaporized cannabis with a 3:1 ratio of THC to CBD. Most notably, these trials are being conducted in Hartford, but 51 other centres across the country are also running similar investigations."